Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Hempel

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Antimicrobial Agents and Chemotherapy|May 1, 2023
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement TherapyLea Marie Schatz, Alexander Brinkmann, Anka Röhr, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2017
Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in ChildrenSilke Gastine, Thomas Lehrnbecher, Carsten Müller, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 10, 2019
Continuous infusion of physostigmine in patients with perioperative septic shock: A pharmacokinetic/pharmacodynamic study with population pharmacokinetic modelingNadine Pinder, Johannes B Zimmermann, Silke Gastine, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 23, 2022
Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MSPatrick Opitz, Sebastian Zimmermann, Anna M Mc Laughlin, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2022
Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mgYi-Han Chien, Gudrun Würthwein, Pablo Zubiaur, et al.
BMC Geriatrics|September 20, 2019
Impact of training and structured medication review on medication appropriateness and patient-related outcomes in nursing homes: results from the interventional study InTherAKTAngelika Mahlknecht, Laura Krisch, Nadja Nestler, et al.
Anti-Cancer Drugs|February 16, 2005
Toxicity and pharmacokinetics of i.v. busulfan in children before stem cell transplantationDoris Oechtering, Brunhild Schiltmeyer, Georg Hempel, et al.
Pediatric Blood & Cancer|September 5, 2009
Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocolGeorg Hempel, Mary V Relling, Giulio de Rossi, et al.
BMC Geriatrics|November 27, 2020
Improving medication appropriateness in nursing homes via structured interprofessional medication-review supported by health information technology: a non-randomized controlled studyJohanna Katharina Dellinger, Stefan Pitzer, Dagmar Schaffler-Schaden, et al.
Molecular Cancer|July 19, 2014
Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signalingChristof Bernemann, Carolin Hülsewig, Christian Ruckert, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|May 1, 2023
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement TherapyLea Marie Schatz, Alexander Brinkmann, Anka Röhr, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2017
Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in ChildrenSilke Gastine, Thomas Lehrnbecher, Carsten Müller, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 10, 2019
Continuous infusion of physostigmine in patients with perioperative septic shock: A pharmacokinetic/pharmacodynamic study with population pharmacokinetic modelingNadine Pinder, Johannes B Zimmermann, Silke Gastine, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 23, 2022
Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MSPatrick Opitz, Sebastian Zimmermann, Anna M Mc Laughlin, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2022
Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mgYi-Han Chien, Gudrun Würthwein, Pablo Zubiaur, et al.
BMC Geriatrics|September 20, 2019
Impact of training and structured medication review on medication appropriateness and patient-related outcomes in nursing homes: results from the interventional study InTherAKTAngelika Mahlknecht, Laura Krisch, Nadja Nestler, et al.
Anti-Cancer Drugs|February 16, 2005
Toxicity and pharmacokinetics of i.v. busulfan in children before stem cell transplantationDoris Oechtering, Brunhild Schiltmeyer, Georg Hempel, et al.
Pediatric Blood & Cancer|September 5, 2009
Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocolGeorg Hempel, Mary V Relling, Giulio de Rossi, et al.
BMC Geriatrics|November 27, 2020
Improving medication appropriateness in nursing homes via structured interprofessional medication-review supported by health information technology: a non-randomized controlled studyJohanna Katharina Dellinger, Stefan Pitzer, Dagmar Schaffler-Schaden, et al.
Molecular Cancer|July 19, 2014
Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signalingChristof Bernemann, Carolin Hülsewig, Christian Ruckert, et al.
Pageof 13